(MedPage Today) — With spironolactone (Aldactone) treatment for acne rising several-fold in recent decades, safety concerns persist for this off-label practice in understudied populations. A database of U.S. insurance claims showed that among… Source link : https://www.medpagetoday.com/dermatology/generaldermatology/114693 Author : Publish date : 2025-03-17 19:35:00 Copyright for syndicated content belongs to the linked Source.
The post Spironolactone Gains Foothold in Acne Amid Unresolved Safety Questions first appeared on News Health.
Author : News Health
Publish date : 2025-03-17 19:35:00
Copyright for syndicated content belongs to the linked Source.